SAINTVILUS ON TECH STOCKS

Endo Pharmaceutical Holdings Inc. (ENDP)

NASDAQ: Health Care

$34.20

0.63 | 1.88%

Today's Range: 33.78 - 35.60

ENDP Avg. Daily Volume: 1,321,200

05/29/12 - 4:00 PM ET

TRADE NOW

Insider Trading

Historical Data	Current	1 Mo. Ago	2 Mo. Ago	3 Mo. Ago	4 Mo. Ago	5 Mo. Ago	6 Mo. Ago

Net Insider Transaction	281,636	223,966	1,562	1,562	1,825	10,025	10,025
Shares Bought	289,004	421,667	197,969	197,969	6,825	10,025	30,613
Shares Sold	7,368	197,701	196,407	196,407	5,000	0	20,588

Institutional Trading

Historical Data	Current	1 Mo. Ago	2 Mo. Ago	3 Mo. Ago	4 Mo. Ago	5 Mo. Ago	6 Mo. Ago

Total Shares Held	124.74M	121.50M	126.36M	126.69M	123.07M	123.07M	122.87M
Shares Bought	19.60M	18.46M	19.79M	19.10M	14.98M	14.98M	15.18M
Shares Sold	20.46M	16.29M	17.61M	16.10M	18.83M	18.83M	18.81M

Latest ENDP Headlines

More Financial News for ENDP

Press Releases for ENDP

Endo Announces Resolution Of Patent Litigation With Watson Pharmaceuticals Related To LidodermÂ® - PR Newswire
Endo Health Solutions Inc. To Present At The Goldman Sachs 33rd Annual Global Healthcare Conference - PR Newswire
Endo Health Solutions Inc. To Present At Jefferies 2012 Global Healthcare Conference - PR Newswire
Endo Health Solutions Inc. Announced As New Name For Endo Pharmaceuticals Holdings Inc. - PR Newswire
Endo Pharmaceuticals To Announce First Quarter 2012 Financial Results On May 1, 2012 - PR Newswire
Qualitest Pharmaceuticals Receives FDA Approval For Levetiracetam Oral Solution, 100 Mg/mL - PR Newswire
Endo Announces Departure Of American Medical Systems President - PR Newswire
Endo Acquires Johnson Matthey's Oxymorphone Patent - PR Newswire
BioDelivery Sciences Provides Business Review And Update In Conjunction With Filing Of Its Annual Report - PR Newswire
Endo Files Amended Citizen Petition Seeking Public FDA Resolution Of Several Safety And Efficacy Issues Prior To Approval Of A Generic Formulation Of LIDODERMÂ® - PR Newswire

See all press releases.

Refresh Stock Quote for Endo Pharmaceutical Holdings Inc. - ENDP

TheStreet Premium Services

Compare All Services

Jim Cramer's Action Alerts PLUS:

Trade right alongside a Wall Street pro — enjoy access to his Charitable Trust portfolio and be sent trade alerts BEFORE he makes a move. Learn More

OptionsProfits:

Get 50+ trade ideas a week from the industry's top options experts. Plus — exclusive commentary on market trends and essential trading tools. Learn More

Real Money:

Our team of professional Wall Street Pros — including Jim Cramer, Doug Kass, and Nicholas Vardy — delivers intelligent analysis, timely trade ideas, and colorful commentary. Learn More

Stocks Under $10:

Break into the market with small- and mid-cap stocks... all $10 or less! David Peltier tells you exactly which low-priced stocks he's buying and selling. Learn More

Dow Jones	S&P 500	NASDAQ	10-Year Note
12,580.69	1,332.42	2,870.99	17.31	Oil * 106.79
UP 125.86	UP 14.60	UP 33.46	DOWN 0.14	10 Yr 1.73% SPDR Gold 151.02
+1.01%	+1.11%	+1.18%	-0.80%	Data delayed 20 minutes

Free Newsletters from TheStreet

We respect your privacy.

Manage Newsletters

Podcasts

Daily RSS Updates

TheStreet Mobile Edition

Connect with TheStreet